Cargando…

The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2

BACKGROUND: Although regulatory T cells (Tregs) play crucial roles in the maintenance of immune hemostasis, the numbers of peripheral Tregs in patients with psoriatic arthritis (PsA) remain unclear. We measured these numbers and the efficacy and safety of low-dose interleukin-2 (IL-2) therapy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jia, Zhang, Sheng-Xiao, Hao, Yu-Fei, Qiu, Meng-Ting, Luo, Jing, Li, Yu-Yao, Gao, Chong, Li, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236566/ https://www.ncbi.nlm.nih.gov/pubmed/32523664 http://dx.doi.org/10.1177/2040622320916014

Ejemplares similares

Autoantibodies in psoriatic arthritis: are they of pathogenic relevance?
por: Zhu, Jing, et al.
Publicado: (2020)

Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis
por: Zhang, Sheng-Xiao, et al.
Publicado: (2021)

Pathological Role of Interleukin-6 in Psoriatic Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial
por: Wang, Jia, et al.
Publicado: (2022)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2023)

Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
por: Szentpetery, Agnes, et al.
Publicado: (2017)

Risk factors associated with osteoporosis and fracture in psoriatic arthritis
por: Wang, Yu, et al.
Publicado: (2021)

Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis
por: Chia, Alfred Yu Ting, et al.
Publicado: (2021)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
por: Widawski, L., et al.
Publicado: (2022)

The Clinical Characteristics of Psoriatic Arthritis: A Cross-Sectional Study Based on the Psoriatic Arthritis Cohort of West China Hospital
por: Wang, Yiyi, et al.
Publicado: (2023)

Psoriatic arthritis
por: Sankowski, Artur Jacek, et al.
Publicado: (2013)

Psoriatic Arthritis
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019)

Altered Fecal Metabolomics and Potential Biomarkers of Psoriatic Arthritis Differing From Rheumatoid Arthritis
por: Wang, Nan, et al.
Publicado: (2022)

Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis
por: Larid, Guillaume, et al.
Publicado: (2022)

Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis
por: Boutet, Marie-Astrid, et al.
Publicado: (2020)

Decreased numbers and sex-based differences of circulating regulatory T cells in patients with seropositive undifferentiated arthritis
por: Niu, Hong-Qing, et al.
Publicado: (2021)

Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis
por: Hagberg, Katrina Wilcox, et al.
Publicado: (2016)

Psoriatic Arthritis: An Update
por: Lloyd, Peter, et al.
Publicado: (2012)

Research progress in psoriatic arthritis-related cardiovascular damage
por: Liu, Ming, et al.
Publicado: (2020)

Reduction of peripheral regulatory T cells in active rheumatoid arthritis patients with coronary artery disease
por: Wang, Yanyan, et al.
Publicado: (2021)

New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis
por: Doyle, Matthew S, et al.
Publicado: (2012)

Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients
por: Tabra, Samar Abdalhamed, et al.
Publicado: (2022)

Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis
por: Bettiol, Alessandra, et al.
Publicado: (2023)

Introduction of a Simplified Psoriatic Arthritis Magnetic Resonance Imaging Score (sPsAMRIS): A Potential Tool for Treatment Monitoring in Peripheral Psoriatic Arthritis
por: Abrar, Daniel B., et al.
Publicado: (2020)

Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)
por: Yang, Fan, et al.
Publicado: (2023)

From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention
por: Zabotti, Alen, et al.
Publicado: (2020)

Elevated serum Dickkopf-1 is a biomarker for bone erosion in patients with psoriatic arthritis
por: Chung, Yukchiu, et al.
Publicado: (2021)

Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Qi, Fei, et al.
Publicado: (2021)

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
por: Bolt, Janne W., et al.
Publicado: (2022)

Cardiovascular Risk in Patients with Psoriatic Arthritis
por: Zhu, Tracy Y., et al.
Publicado: (2012)

Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China
por: Chen, Miao, et al.
Publicado: (2021)

Decreased absolute number of peripheral regulatory T cells in patients with idiopathic retroperitoneal fibrosis
por: Liu, Lu, et al.
Publicado: (2022)

Measuring Disease Activity in Psoriatic Arthritis
por: Wong, Priscilla C. H., et al.
Publicado: (2012)

Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis
por: Dolcino, Marzia, et al.
Publicado: (2015)

Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis
por: Pinto Tasende, Jose A., et al.
Publicado: (2023)

Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study)
por: van der Togt, Céleste J.T., et al.
Publicado: (2022)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: Chandran, Vinod
Publicado: (2010)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

Macrophage dysfunction in Psoriatic Arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l7k2cuqffaq0nd8k9kcqdegoao